Frade-Sosa, B.; Chacur, C.A.; Augé, J.M.; Ponce, A.; Sarmiento-Monroy, J.C.; Azuaga, A.B.; Sapena, N.; RamÃrez, J.; Ruiz-Esquide, V.; Morlà , R.;
et al. Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors. Cancers 2023, 15, 2984.
https://doi.org/10.3390/cancers15112984
AMA Style
Frade-Sosa B, Chacur CA, Augé JM, Ponce A, Sarmiento-Monroy JC, Azuaga AB, Sapena N, RamÃrez J, Ruiz-Esquide V, Morlà R,
et al. Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors. Cancers. 2023; 15(11):2984.
https://doi.org/10.3390/cancers15112984
Chicago/Turabian Style
Frade-Sosa, Beatriz, Chafik Alejandro Chacur, Josep M. Augé, Andrés Ponce, Juan C. Sarmiento-Monroy, Ana Belén Azuaga, Nuria Sapena, Julio RamÃrez, Virginia Ruiz-Esquide, Rosa Morlà ,
and et al. 2023. "Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors" Cancers 15, no. 11: 2984.
https://doi.org/10.3390/cancers15112984
APA Style
Frade-Sosa, B., Chacur, C. A., Augé, J. M., Ponce, A., Sarmiento-Monroy, J. C., Azuaga, A. B., Sapena, N., RamÃrez, J., Ruiz-Esquide, V., Morlà , R., Farietta, S., Corzo, P., Cañete, J. D., SanmartÃ, R., & Gómez-Puerta, J. A.
(2023). Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors. Cancers, 15(11), 2984.
https://doi.org/10.3390/cancers15112984
